# PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (INTRAVENOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS

> **NCT01651923** · PHASE1 · UNKNOWN · sponsor: **Azidus Brasil** · enrollment: 60 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT01651923
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2012-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01651923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01651923, "PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (INTRAVENOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01651923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*